Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dermata Therapeutics, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-KS-110-Q10-Q
Net income    -12.3-10.9-10.5-8.3-4.6-4.1
Stock-based compensation    2.72.53.51.41.31.2
Change in working capital   [+]  2.52.22.6 0.70.3
Other operating activities      -0.62.5-0.1-0.1
Cash from operations    -7.8-6.9-5.1-3.8-2.8-2.7
   
Capital expenditures    0.00.00.00.00.00.0
Cash from investing    0.00.00.00.00.00.0
   
Issuance of common stock, net    4.3     
Other cash from financing    0.0 1.6  1.9
Cash from financing    4.30.01.61.91.91.9
   
Free cash flow    -7.8-6.9-5.1-3.8-2.8-2.7
        Per share (diluted)    ($2.98)($2.35)($1.54)($1.41)($1.47)($1.43)
   
Cash paid for interest        0.00.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy